Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory study of human urinary kallidinogenase for leptomeningeal collateral function in ischemic stroke with intracranial large-vessel occlusion
ChiCTR-TRC-14004218Phase 4Not yet recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Jan 2014
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of Human urinary kallidinogenase in ischemic stroke (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoints: NIHSS score and regional leptomeningeal collateral score. Planned start Jan 2014; status: not yet recruiting.
02
Drugs
Human urinary kallidinogenase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR-TRC-14004218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004218.